Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 28-10-2026
NAV ₹16.39(R) +1.01% ₹17.18(D) +1.01%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 16.34% -% -% -% -%
Direct 18.36% -% -% -% -%
Benchmark
SIP (XIRR) Regular 22.42% -% -% -% -%
Direct 24.56% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 28-10-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 16.39
0.1600
1.0100%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 17.18
0.1700
1.0100%

Review Date: 28-10-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -2.39 -0.82
-3.15
-4.64 | -1.64 4 | 17 Very Good
3M Return % 0.28 2.14
-0.96
-5.58 | 2.86 6 | 17 Good
6M Return % 15.79 15.02
11.99
5.36 | 17.25 2 | 17 Very Good
1Y Return % 16.34 20.00
12.42
2.50 | 21.45 3 | 16 Very Good
1Y SIP Return % 22.42
16.90
4.02 | 26.04 4 | 16 Very Good
Return data last Updated On : Oct. 28, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -2.26 -0.82 -3.05 -4.51 | -1.54 4 | 17 Very Good
3M Return % 0.72 2.14 -0.63 -5.25 | 3.28 6 | 17 Good
6M Return % 16.79 15.02 12.75 5.76 | 18.16 2 | 17 Very Good
1Y Return % 18.36 20.00 13.94 3.96 | 22.81 3 | 16 Very Good
1Y SIP Return % 24.56 19.09 5.50 | 28.03 4 | 15 Very Good
Return data last Updated On : Oct. 28, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
28-10-2026 16.389 17.185
27-10-2026 16.225 17.013
26-10-2026 15.745 16.508
23-10-2026 15.471 16.219
22-10-2026 15.615 16.369
21-10-2026 15.597 16.35
19-10-2026 15.72 16.477
16-10-2026 15.866 16.628
15-10-2026 15.911 16.675
14-10-2026 15.957 16.722
13-10-2026 16.122 16.894
12-10-2026 16.201 16.976
09-10-2026 16.152 16.922
08-10-2026 16.056 16.821
07-10-2026 16.459 17.242
06-10-2026 16.512 17.297
05-10-2026 16.297 17.071
01-10-2026 16.443 17.22
30-09-2026 16.503 17.282
29-09-2026 16.808 17.601
28-09-2026 16.79 17.582

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.